Noida, UP -- (SBWIRE) -- 06/24/2014 -- The US NIPT market has evolved due to advancement in technology, rising birth rate across the nation. Rising awareness of NIPT among gynecologists and high risk pregnant women are key factors driving the growth of the NIPT market. The country’s market is occupied by four companies. These companies are also expanding their foothold in this segment through collaborations or acquisitions with certain laboratories. Besides, several other players are likely to enter this potential market.
The market has propelled dramatically with respect to the number of test volumes by key players. This increase in the test volumes has been attributed due to certain reimbursement rates laid down by insurance companies across US. Sequenom, one of the leading players in US NIPT market has performed approximately 140,000 tests during 2013. The company has even reported a minimum of US$ 235 co-pay for those covered by insurance. Based on the above mentioned facts, US NIPT market has been estimated to grow at a CAGR of over 20% by the end of 2018.
Research Analysis & Highlights
Our latest research report “US Non-Invasive Prenatal Testing Market Outlook 2018”, provides a prudent analysis on the current and future size of the market weighing the possible pessimistic and optimistic scenarios. In addition to it, the report has even mentioned the potential market for high and medium to high risk pregnancy patients. The demographic scenario of United States has been discussed with focus on the current and future number of births, with the demographics segregated by age and state.
It also provides a transparent view on the present regulatory framework elaborating on the existing loopholes. Our report has discussed the views of regulatory authorities, players and consumers towards the regulatory stringency and the direction of regulations in the future have also been covered.
Currently, the US NIPT sector is characterized by the presence of players like Sequenom, Verinata, Ariosa and Natera. These players have been profiled with their strengths and weaknesses and latest developments in the field of NIPT. The report is a must buy for new market entrants in the diagnostics field, planning to enter the prenatal segment.
Some of the key findings of the report are:
- Rising Rate of Births among High Risk Women Driving the NIPT Market
- Highly Untapped US NIPT Market, a Lucrative Option
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM668.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.